---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-001362"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2022-02-16T23:59:59+00:00"
generated_at: "2026-06-27T07:29:05.162506+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q4 revenue $28.2M, FY21 $102.6M (+105%); guides FY22 $142-150M; CEO adds Chair

## Summary
- Q4 revenue $28.2M (+63% YoY); FY21 revenue $102.6M (+105.5% YoY). GAAP EPS ($0.87); non-GAAP EPS ($0.77).
- FY21 GAAP net loss $131.9M ($2.89/share); non-GAAP net loss $114.5M ($2.51/share).
- Q4 gross margin 11.8% (vs 2.4% YoY); cash and investments $372.8M at Dec 31, 2021.
- FY2022 revenue guidance $142M-$150M representing 38%-46% growth over FY2021.
- CEO Leslie Trigg appointed Chair of Board; D. Keith Grossman becomes Lead Independent Director.

## SEC filing metadata
- accession: 0000950170-22-001362
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2022-02-16T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017022001362/0000950170-22-001362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017022001362/om-20220216.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-001362
- JSON: https://secwatch.observer/filing/0000950170-22-001362.json
- Plain text: https://secwatch.observer/filing/0000950170-22-001362.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.